RNF227
gene geneOn this page
Summary
RNF227 (ring finger protein 227, HGNC:27571) is a protein-coding gene on chromosome 17p13.1, encoding RING finger protein 227 (A6NIN4).
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in protein ubiquitination.
Source: NCBI Gene 284023 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001358699
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27571 |
| Approved symbol | RNF227 |
| Name | ring finger protein 227 |
| Location | 17p13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000179859 |
| Ensembl biotype | protein_coding |
| Entrez | 284023 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000324348, ENST00000635932, ENST00000640240
RefSeq mRNA: 1 — MANE Select: NM_001358699
NM_001358699
CCDS: CCDS86570
Canonical transcript exons
ENST00000324348 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001246380 | 7913339 | 7915577 |
| ENSE00001246383 | 7915679 | 7916289 |
Expression profiles
Bgee: expression breadth ubiquitous, 200 present calls, max score 98.75.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.4178 / max 150.5887, expressed in 1263 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 164331 | 2.5179 | 1033 |
| 164332 | 0.8999 | 327 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| upper arm skin | UBERON:0004263 | 98.75 | gold quality |
| upper leg skin | UBERON:0004262 | 93.79 | gold quality |
| oviduct epithelium | UBERON:0004804 | 93.79 | gold quality |
| skin of leg | UBERON:0001511 | 93.43 | gold quality |
| zone of skin | UBERON:0000014 | 92.39 | gold quality |
| skin of abdomen | UBERON:0001416 | 91.05 | gold quality |
| skin of hip | UBERON:0001554 | 88.89 | gold quality |
| buccal mucosa cell | CL:0002336 | 87.28 | gold quality |
| gingival epithelium | UBERON:0001949 | 83.44 | gold quality |
| sural nerve | UBERON:0015488 | 80.35 | gold quality |
| nipple | UBERON:0002030 | 80.34 | gold quality |
| mammalian vulva | UBERON:0000997 | 79.79 | gold quality |
| ileal mucosa | UBERON:0000331 | 79.23 | silver quality |
| fallopian tube | UBERON:0003889 | 79.15 | gold quality |
| cortical plate | UBERON:0005343 | 78.17 | gold quality |
| gingiva | UBERON:0001828 | 78.14 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.07 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 77.34 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 77.30 | gold quality |
| cerebellar cortex | UBERON:0002129 | 77.26 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 77.09 | gold quality |
| cerebellum | UBERON:0002037 | 76.70 | gold quality |
| right uterine tube | UBERON:0001302 | 76.68 | gold quality |
| primary visual cortex | UBERON:0002436 | 74.62 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 74.54 | gold quality |
| body of uterus | UBERON:0009853 | 74.49 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 74.36 | gold quality |
| ventricular zone | UBERON:0003053 | 74.27 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 73.83 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 73.56 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6142 | no | 19.11 |
| E-ANND-3 | no | 2.67 |
| E-MTAB-5061 | no | 2.47 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rnf227 | ENSMUSG00000043419 |
| rattus_norvegicus | Rnf227 | ENSRNOG00000021540 |
| drosophila_melanogaster | roq | FBGN0036621 |
Paralogs (5): RC3H2 (ENSG00000056586), RC3H1 (ENSG00000135870), RNF182 (ENSG00000180537), RNF224 (ENSG00000233198), RNF228 (ENSG00000288658)
Protein
Protein identifiers
RING finger protein 227 — A6NIN4 (reviewed: A6NIN4)
Alternative names: Long intergenic non-protein coding RNA 2581
All UniProt accessions (3): A0A1B0GTZ6, A0A2Y9D085, A6NIN4
RefSeq proteins (1): NP_001345628* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001841 | Znf_RING | Domain |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR017907 | Znf_RING_CS | Conserved_site |
| IPR027370 | Znf-RING_euk | Domain |
| IPR027952 | DUF4632 | Domain |
| IPR051435 | RING_finger_E3_ubiq-ligases | Family |
Pfam: PF13445, PF15451
UniProt features (4 total): chain 1, zinc finger region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NIN4-F1 | 69.55 | 0.18 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 38 (showing top):
TSENG_IRS1_TARGETS_UP, YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP, GOLDRATH_ANTIGEN_RESPONSE, RAMALHO_STEMNESS_DN, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, CUI_TCF21_TARGETS_2_UP, CHEN_ETV5_TARGETS_TESTIS, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP, TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP, ZWANG_EGF_PERSISTENTLY_UP, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, YAP1_DN
GO Biological Process (1): protein ubiquitination (GO:0016567)
GO Molecular Function (3): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein modification by small protein conjugation | 1 |
| transition metal ion binding | 1 |
| ubiquitin-protein transferase activity | 1 |
| ubiquitin-like protein ligase activity | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
58 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RNF227 | GPR152 | Q8TDT2 | 239 |
| RNF227 | GPR171 | O14626 | 193 |
| RNF227 | GPR82 | Q96P67 | 158 |
| RNF227 | GPR158 | Q5T848 | 156 |
| RNF227 | GPR162 | Q16538 | 141 |
| RNF227 | PNMA8A | Q86V59 | 116 |
| RNF227 | PNMA8C | A0A1B0GUJ8 | 116 |
| RNF227 | TMEM59L | Q9UK28 | 110 |
| RNF227 | CXorf66 | Q5JRM2 | 72 |
| RNF227 | RPSA | P08865 | 72 |
| RNF227 | PPP1R26 | Q5T8A7 | 70 |
| RNF227 | MRPS2 | Q9Y399 | 70 |
| RNF227 | SMKR1 | H3BMG3 | 70 |
| RNF227 | REELD1 | A0A1B0GV85 | 65 |
| RNF227 | RPS16 | P17008 | 51 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A286YF58, A0A494C0N9, A0A494C0Y3, A0A7I2V3R4, A2VDX9, A6NIN4, D3YXK1, G3UXB3, O15370, O15522, O35392, O70218, O70220, O89113, P0DPE3, P12980, P17542, P22091, P28283, P82976, Q04890, Q05916, Q05917, Q13461, Q14V87, Q15270, Q19A40, Q5T230, Q5VY09, Q63244, Q6F5E0, Q6SPE9, Q6SPF0, Q7RTU7, Q80WY3, Q8TD94, Q8WY41, Q8WZ71, Q91XV7, Q96Q04
Diamond homologs: A6NIN4, D2H788, D3ZBM4, Q3UIW8, Q6INB3, Q8C432, Q8N6D2, Q9DCB3, A0A7I2V3R4, O70277, O75382, Q13049, Q3T0Y9, Q6IMG5, Q8CH72, Q8K0W3, Q9FY48, Q9H0X6, Q9NXI6, Q9R1R2, A4IF63, D2GXS7, D3ZQG6, E1BD59, F7H9X2, M0QZC1, P0DH78, Q80VI1, Q8QZS5, Q9C040, Q9D7D1, Q9ESN6, Q9D241
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1204 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:7916121:G:C | F25L | 0.980 |
| 17:7916121:G:T | F25L | 0.980 |
| 17:7916123:A:G | F25L | 0.980 |
| 17:7915959:G:C | F79L | 0.972 |
| 17:7915959:G:T | F79L | 0.972 |
| 17:7915961:A:G | F79L | 0.972 |
| 17:7916053:C:T | C48Y | 0.965 |
| 17:7916134:C:G | C21S | 0.963 |
| 17:7916135:A:T | C21S | 0.963 |
| 17:7916052:G:C | C48W | 0.961 |
| 17:7916099:G:T | R33S | 0.961 |
| 17:7916134:C:T | C21Y | 0.957 |
| 17:7916054:A:G | C48R | 0.955 |
| 17:7915967:A:G | C77R | 0.954 |
| 17:7916053:C:G | C48S | 0.954 |
| 17:7916054:A:T | C48S | 0.954 |
| 17:7916143:C:G | C18S | 0.954 |
| 17:7916144:A:T | C18S | 0.954 |
| 17:7916101:G:T | P32H | 0.953 |
| 17:7916135:A:G | C21R | 0.952 |
| 17:7916143:C:T | C18Y | 0.952 |
| 17:7916061:G:C | H45Q | 0.950 |
| 17:7916061:G:T | H45Q | 0.950 |
| 17:7916133:G:C | C21W | 0.948 |
| 17:7916144:A:G | C18R | 0.939 |
| 17:7916122:A:G | F25S | 0.935 |
| 17:7916134:C:A | C21F | 0.935 |
| 17:7916143:C:A | C18F | 0.934 |
| 17:7915957:C:T | C80Y | 0.933 |
| 17:7915957:C:G | C80S | 0.929 |
dbSNP variants (sampled 300 via entrez): RS1000513172 (17:7914668 A>C,G), RS1000570247 (17:7915123 G>T), RS1001115353 (17:7914246 T>A), RS1001125222 (17:7914490 T>C), RS1001518340 (17:7913296 C>T), RS1001748186 (17:7917219 G>A,C,T), RS1001802031 (17:7917551 C>T), RS1002136129 (17:7916217 G>T), RS1003181819 (17:7914471 T>TGGGAGGCGGAGGCTGCA), RS1003828165 (17:7916330 G>A), RS1004967857 (17:7913965 G>C), RS1005587607 (17:7916798 C>G,T), RS1005714059 (17:7913878 T>A,C,G), RS1005872647 (17:7914921 C>A,G,T), RS1005881409 (17:7913848 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects expression, increases expression | 3 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| licochalcone B | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Niclosamide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Thapsigargin | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
| Magnetite Nanoparticles | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.